Helsinn Healthcare - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsHelsinn Healthcare

Helsinn Healthcare

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Akynzeo	Fosnetupitant, Palonosetron, Netupitant	2018-04-19	2023-2037	Neoplasms , Vomiting , Nausea
Aloxi	Palonosetron	2003-07-25	2023-2037	Neoplasms , Vomiting , Nausea
Truseltiq	Infigratinib	2021-05-28	2028-2034	Cholangiocarcinoma

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

multiple myeloma

,

plasma cell neoplasms

,

,

postoperative nausea and vomiting

,

female genital neoplasms

,

drug-related side effects and adverse reactions

,

uterine cervical neoplasms

,

,

healthy volunteers/patients

,

gallbladder neoplasms

,

,

breast neoplasms

,

,

drug-related side effects and adverse reactions

,

uterine cervical neoplasms

,

colorectal neoplasms

,

electroacupuncture

,

,

,

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

liver neoplasms

,

,

,

,

central nervous system neoplasms

,

cholangiocarcinoma

,

,

urinary bladder neoplasms

,

transitional cell carcinoma

healthy volunteers/patients

,

myelodysplastic syndromes

,

,

,

myeloproliferative disorders

,

primary myelofibrosis

,

,

myeloid leukemia acute

,

myeloid leukemia

pancreatic neoplasms

intestinal neoplasms

,

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

bcr-abl positive chronic myelogenous leukemia

,

myelomonocytic leukemia chronic

,

,

myeloid leukemia chronic-phase

,

myeloid leukemia

,

neoplasm metastasis

,

myelomonocytic leukemia juvenile

,

,

refractory anemia with excess of blasts

,

,

,

lymphoid leukemia

,

refractory anemia

,

,

,

,

,

small cell lung carcinoma

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

,

central nervous system neoplasms

,

,

nervous system neoplasms

,

non-small-cell lung carcinoma

,

bile duct neoplasms

,

liver neoplasms

,

cholangiocarcinoma

,

gallbladder neoplasms

,

breast neoplasms

,

male breast neoplasms

,

colorectal neoplasms

,

renal cell carcinoma

,

kidney neoplasms

,

biliary tract neoplasms

,

urinary bladder neoplasms

,

transitional cell carcinoma

Sodium chloride

healthy volunteers/patients

,

,

,

,

staphylococcal infections

,

,

kidney neoplasms

,

insulin resistance

,

,

,

spine osteoarthritis

,

,

,

castration-resistant prostatic neoplasms

,

small cell carcinoma

,

urethral neoplasms

,

transitional cell carcinoma

,

neuroendocrine tumors

,

neuroendocrine carcinoma

,

,

,

venous thrombosis

,

urinary bladder neoplasms

,

renal insufficiency

,

,

,

chronic kidney failure

,

colorectal neoplasms

,

,

invasive hydatidiform mole

,

respiratory syncytial viruses

,

urologic neoplasms

,

infectious skin diseases

,

,

soft tissue infections

,

,

disease progression

,

rheumatoid arthritis

,

,

pancreatic neoplasms

,

general anesthesia

,

urinary tract infections

,

,

respiratory tract infections

,

photorefractive keratectomy

,

interstitial lung diseases

,

multiple myeloma

,

plasma cell neoplasms

,

non-hodgkin lymphoma

,

,

non-muscle invasive bladder neoplasms

,

carcinoma in situ

,

squamous intraepithelial lesions

,

st elevation myocardial infarction

,

,

adenosquamous carcinoma

,

,

,

non-small-cell lung carcinoma

,

,

communicable diseases

,

,

squamous cell carcinoma of head and neck

,

uterine cervical neoplasms

,

,

prostatic neoplasms

,

breast neoplasms

,

small cell lung carcinoma

,

squamous cell carcinoma

,

hepatocellular carcinoma

,

liver neoplasms

,

papillomavirus infections

,

,

,

cystic fibrosis

,

clostridium infections

,

ovarian epithelial carcinoma

,

cytomegalovirus infections

,

renal cell carcinoma

,

triple negative breast neoplasms

,

fallopian tube neoplasms

,

stomach neoplasms

,

head and neck neoplasms

,

,

intraabdominal infections

,

condylomata acuminata

,

myocardial infarction

,

,

pulmonary fibrosis

,

,

uterine cervical dysplasia

,

squamous intraepithelial lesions of the cervix

,

pneumococcal infections

,

essential hypertension

,

bacterial conjunctivitis

,

,

peritoneal neoplasms

,

surgical wound infection

,

esophageal squamous cell carcinoma

,

replacement arthroplasty knee

,

replacement arthroplasty hip

,

,

blood coagulation

,

,

persistent infection

,

vaginal neoplasms

,

vulvar neoplasms

,

respiratory syncytial virus infections

,

left ventricular dysfunction

,

,

cardiopulmonary bypass

,

coronary artery bypass

,

ventricular dysfunction

,

keratoconjunctivitis sicca

,

dry eye syndromes

,

,

,

pneumococcal pneumonia

,

,

obstructive sleep apnea

,

sleep apnea syndromes

,

,

spondylarthropathies

,

spondylarthritis

,

,

,

,

,

ebola hemorrhagic fever

,

neuromuscular blockade

,

ovarian neoplasms

,

diabetes mellitus

,

esophageal neoplasms

,

kidney diseases

,

invasive candidiasis

,

,

type 2 diabetes mellitus

,

,

postoperative nausea and vomiting

,

,

,

,

,

diabetic nephropathies

,

,

,

uterine neoplasms

,

intestinal diseases

,

,

,

metabolic syndrome

,

bipolar disorder

metabolic bone diseases

,

,

pancreatic neoplasms

,

,

neoplasm metastasis

,

,

,

non-small-cell lung carcinoma

,

wasting syndrome

,

,

,

healthy volunteers/patients

,

,

pituitary dwarfism

,

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

megakaryoblastic leukemia acute

,

monocytic leukemia acute

,

myelomonocytic leukemia acute

,

myeloid leukemia

,

erythroblastic leukemia acute

,

,

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

1

2

>

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use